USSTOCK.TODAY
Market Closed
Log in Sign up

Verastem Announces Q3 2026 Revenue Growth and Management Changes

The Motley Fool +1 · ·by G4L

VSTM
VSTM Verastem Inc
$8.73 +0.34%
View chart & analysis →
  1. 1Verastem achieved net product revenue of $24 million in Q3 2026, marking a 114% increase in net product revenue compared to Q3 2025.
  2. 2Verastem raised approximately $250 million in total proceeds in October.
  3. 3President and CEO Daniel Patterson will step down at the end of 2026.

So what's the key point?

Verastem's product revenue grew significantly to $24 million. Changes in company operations are expected as the management team will be replaced.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Verastem Oncology shares surge 18% following release of early cancer treatment data Barrons.com +1 · Oct 15Sprout Social beats 2Q adjusted EPS estimate at 26 cents Associated Press +1 · Aug 7Sensata Technologies Hits Record $13.1 Million in Q3 2026 Revenue The Motley Fool +1 · 3d ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news